By using our website, you are agreeing to cookies being stored and Google Analytics being used on your device in order to offer the best possible service. You can find more information on thishere.
Austria.
Bridge to New Markets.

Lancor Scientific researches in Austria

Lancor Scientific Chief Medical Officer und Prokurtist Prof. Dr. Roland Schlesinger

The method should provide 90 percent accuracy, whereas the precision of conventional Pap tests is only 60-70 percent. A research laboratory was set up in Graz for further research on the patented Opto-magnetic Imaging Spectroscopy (OMIS) process. The company cooperates with the Graz University of Technology, the Medical University of Graz and Sigmund Freud University in Vienna. Lancor established a subsidiary in Austria for this purpose. Research will be supported by public funding over a period of five years. The device itself is expected to be already launched on the marketplace in 2019. The company hopes to have 10,000 devices available in the next five years.  

 “Identifying cancer at an early stage is the key to save lives. Lancor Scientific has set itself the task of making an accurate and cost-effective cancer identification technology available around the world. The confidence placed in us by the Austrian government and the partnership with specialists at the Graz University of Technology form the basis for continuing this journey and making a minimum of 10,000 devices available over the next five years. In this case, 500,000 cancer tests can be carried out each day”, says Chief Medical Officer at Lancor Scientific Schlesinger Roland.

Share on Facebook Share on Facebook Share on Twitter Share on Twitter Share on Linkedin Share on Linkedin

Testimonials

Events

Meet us at events, seminars and trade shows - worldwide.

  • Meet us @ The Grow by SalsUp

    20.04.2021/ 16:30 Uhr - 19:00 Uhr, Wien, Österreich

  • Ukrainian-Austrian Business Forum

    27.4.2021/ 14.00 (CET) , Online Conference

Austria Map

Find the perfect location for your company

Austria stands out due to its long-term reliable and stable conditions. These features are particularly important for a research-based company such as Boehringer Ingelheim. Furthermore, Vienna is a city with a good research infrastructure and a high quality of life, and is thus also an interesting place for highly qualified employees from Austria and abroad.

Boehringer Ingelheim

Logo
More testimonials

news from the business location Austria

Austrians conduct research in New York on low-priced vaccine

Two Austrians are conducting research in New York on a vaccine against the coronavirus which is designed to be available at a particularly low price and also be easy to dispense.

Shared Mobility in Austria!

"A green planet with mobility from everyone, for everyone" has continuously been the motto of GO Sharing.

More news All blog posts